Clinical trial
Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes…
NCT00107107 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00107107 |
|---|---|
| Title | Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus |
| Official title | A Multicenter, Open-Label, Extension Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus Completing Protocol 137-150 |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 1 |
| Intervention type | Drug |
| Interventions | pramlintide acetate |
| Enrollment | 190 |
| Start date | Nov 1, 2002 |
| Primary completion | Jun 1, 2005 |
| Completion | Jun 1, 2005 |
| First posted | Apr 6, 2005 |
| Last update posted | Sep 23, 2015 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: